Stone, O. A.; Zhou, B.; Red-Horse, K.; Stainier, D. Y. R.: Endothelial ontogeny and the establishment of vascular heterogeneity. BIOESSAYS 43 (7), e2100036 (2021)
Lalonde, S.; Stone, O. A.; Lessard, S.; Lavertu, A.; Desjardins, J.; Beaudoin, M.; Rivas, M.; Stainier, D. Y. R.; Lettre, G.: Frameshift indels introduced by genome editing can lead to in-frame exon skipping. PLOS ONE 12 (6), e0178700 (2017)
Matsuoka, R. L.; Rossi, A.; Stone, O. A.; Stainier, D. Y. R.: CNS-resident progenitors direct the vascularization of neighboring tissues. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 114 (38), pp. 10137 - 10142 (2017)
Researchers at the Max Planck Institute develop a new pharmacological approach that specifically targets receptor interactions – with implications for immune defense and blood pressure regulation
A team of researchers at the Max Planck Institute for Heart and Lung Research, led by Prof. Dr. Didier Y.R. Stainier, has been awarded a prestigious ERC Proof of Concept (PoC) grant to advance a groundbreaking RNA-based therapeutic strategy for Duchenne Muscular Dystrophy (DMD).